Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Intrasphincteric Botulinum Toxin for the Treatment of Achalasia
Ist Teil von
The New England journal of medicine, 1995-03, Vol.332 (12), p.774-778
Ort / Verlag
Boston, MA: Massachusetts Medical Society
Erscheinungsjahr
1995
Quelle
MEDLINE
Beschreibungen/Notizen
Achalasia is a disorder of esophageal motility characterized by the absence of peristalsis, an elevated pressure of the lower esophageal sphincter, and the failure of the lower esophageal sphincter to relax during swallowing. The usual treatment for achalasia — balloon dilation or myotomy of the lower esophageal sphincter — is aimed at lowering the resting pressure of the sphincter.
1
We hypothesized that locally injected botulinum toxin, a potent inhibitor of the release of acetylcholine from nerve endings, could be effective in the treatment of achalasia. This hypothesis was based on the concept that the net sphincter tone in the gut . . .